[SCHEDULE 13G 02 (Amendment No. CHIPMOS TECHNOLOGIES BERMUDA LTD (Name of Issuer) Common Stock G2110R114 Calendar Year 2015 x o o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the]
[SCHEDULE 13G/A Amendment No. 10 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 2,876,775 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED BY]
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan Dr. S.K. Chen ChipMOS TECHNOLOGIES (Bermuda) LTD. +886-6-507-7712 s.k._chen@chipmos.com In the U.S. David Pasquale Global IR Partners +1-914-337-8801 dpasquale@globalirpartners.com ChipMOS REPORTS JANUARY 2016 REVENUE; TAINAN OPERATIONS FULLY RESTORED ON FEBRUARY 6, 2016 AFTER VERY MINOR IMPACT Hsinchu, February 12, 2016 Consolidated Monthly Revenues (Unaudited)]
[Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,665,600 Item 6: 0 Item 7: 8,176,400 Item 8: 0 Item 9: 8,176,400 Item 11: 8.479% Item 12: HC Cusip #G6647N108 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 5: 0]
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer EX-32.1 4 f10q1215ex32i_chinajojo.htm CERTIFICATION] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q1215ex32ii_chinajojo.htm CERTIFICATION]
